BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29858935)

  • 1. Assessment of multiphasic contrast-enhanced MR textures in differentiating small renal mass subtypes.
    Hoang UN; Mojdeh Mirmomen S; Meirelles O; Yao J; Merino M; Metwalli A; Marston Linehan W; Malayeri AA
    Abdom Radiol (NY); 2018 Dec; 43(12):3400-3409. PubMed ID: 29858935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
    Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
    AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small (< 4 cm) Renal Mass: Differentiation of Oncocytoma From Renal Cell Carcinoma on Biphasic Contrast-Enhanced CT.
    Sasaguri K; Takahashi N; Gomez-Cardona D; Leng S; Schmit GD; Carter RE; Leibovich BC; Kawashima A
    AJR Am J Roentgenol; 2015 Nov; 205(5):999-1007. PubMed ID: 26496547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
    Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
    Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses.
    Lee-Felker SA; Felker ER; Tan N; Margolis DJ; Young JR; Sayre J; Raman SS
    AJR Am J Roentgenol; 2014 Nov; 203(5):W516-24. PubMed ID: 25341166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal cortical tumors: use of multiphasic contrast-enhanced MR imaging to differentiate benign and malignant histologic subtypes.
    Vargas HA; Chaim J; Lefkowitz RA; Lakhman Y; Zheng J; Moskowitz CS; Sohn MJ; Schwartz LH; Russo P; Akin O
    Radiology; 2012 Sep; 264(3):779-88. PubMed ID: 22829683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.
    Sun MR; Ngo L; Genega EM; Atkins MB; Finn ME; Rofsky NM; Pedrosa I
    Radiology; 2009 Mar; 250(3):793-802. PubMed ID: 19244046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted imaging versus contrast-enhanced MR imaging for the differentiation of renal oncocytomas and chromophobe renal cell carcinomas.
    Zhong Y; Wang H; Shen Y; Guo A; Wang J; Kang S; Ma L; Pan J; Ye H
    Eur Radiol; 2017 Dec; 27(12):4913-4922. PubMed ID: 28631081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtype Differentiation of Small (≤ 4 cm) Solid Renal Mass Using Volumetric Histogram Analysis of DWI at 3-T MRI.
    Li A; Xing W; Li H; Hu Y; Hu D; Li Z; Kamel IR
    AJR Am J Roentgenol; 2018 Sep; 211(3):614-623. PubMed ID: 29812980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of Contrast-enhanced US for Differentiating Benign from Malignant Solid Small Renal Masses.
    Atri M; Tabatabaeifar L; Jang HJ; Finelli A; Moshonov H; Jewett M
    Radiology; 2015 Sep; 276(3):900-8. PubMed ID: 25919803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of diffusion-weighted MRI and contrast-enhanced MRI for differentiation between solid renal masses and renal cell carcinoma subtypes.
    Serter A; Onur MR; Coban G; Yildiz P; Armagan A; Kocakoc E
    Abdom Radiol (NY); 2021 Mar; 46(3):1041-1052. PubMed ID: 32930832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep learning and radiomics: the utility of Google TensorFlow™ Inception in classifying clear cell renal cell carcinoma and oncocytoma on multiphasic CT.
    Coy H; Hsieh K; Wu W; Nagarajan MB; Young JR; Douek ML; Brown MS; Scalzo F; Raman SS
    Abdom Radiol (NY); 2019 Jun; 44(6):2009-2020. PubMed ID: 30778739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging.
    Taouli B; Thakur RK; Mannelli L; Babb JS; Kim S; Hecht EM; Lee VS; Israel GM
    Radiology; 2009 May; 251(2):398-407. PubMed ID: 19276322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumours.
    Cornelis F; Tricaud E; Lasserre AS; Petitpierre F; Bernhard JC; Le Bras Y; Yacoub M; Bouzgarrou M; Ravaud A; Grenier N
    Eur Radiol; 2014 May; 24(5):1068-80. PubMed ID: 24557052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative multiparametric MR analysis of small renal lesions: correlation with surgical pathology.
    Yano M; Fowler KJ; Srisuwan S; Salter A; Siegel CL
    Abdom Radiol (NY); 2018 Dec; 43(12):3390-3399. PubMed ID: 29691619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 1 papillary renal cell carcinoma: differentiation from Type 2 papillary RCC on multiphasic MDCT.
    Young JR; Coy H; Douek M; Lo P; Sayre J; Pantuck AJ; Raman SS
    Abdom Radiol (NY); 2017 Jul; 42(7):1911-1918. PubMed ID: 28265706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small renal masses (≤ 4 cm): differentiation of oncocytoma from renal clear cell carcinoma using ratio of lesion to cortex attenuation and aorta-lesion attenuation difference (ALAD) on contrast-enhanced CT.
    Gentili F; Bronico I; Maestroni U; Ziglioli F; Silini EM; Buti S; de Filippo M
    Radiol Med; 2020 Dec; 125(12):1280-1287. PubMed ID: 32385827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.
    Wang H; Cheng L; Zhang X; Wang D; Guo A; Gao Y; Ye H
    Radiology; 2010 Oct; 257(1):135-43. PubMed ID: 20713607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma.
    Pierorazio PM; Hyams ES; Tsai S; Feng Z; Trock BJ; Mullins JK; Johnson PT; Fishman EK; Allaf ME
    Urology; 2013 Jun; 81(6):1265-71. PubMed ID: 23601445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcomatoid Renal Cell Carcinoma and Collecting Duct Carcinoma: Discrimination From Common Renal Cell Carcinoma Subtypes and Benign RCC Mimics on Multiphasic MDCT.
    Young JR; Young JA; Margolis DJA; Sauk S; Sayre J; Pantuck AJ; Raman SS
    Acad Radiol; 2017 Oct; 24(10):1226-1232. PubMed ID: 28528853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.